Suppliers / Meghmani

Meghmani

India 293 employees Updated 9 July 2026

Meghmani is an API manufacturer based in India. It holds 3 active US drug master files and 2 valid CEPs. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 3 February 2026 as VAI.

3
active US DMFs
2
valid CEPs
5
registered plants 2 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 3 February 2026 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Ahmedabad, India Not on file
Dahej, India Not on file
Dahej, India 3030599291
Bharuch, India 3005404478
Dahej, India Not on file

What they file, and where

Molecule Regulators Docs
Acetaminophen EDQM, US FDA 5

Also appears on these molecule pages

Acetaminophen API Paracetamol API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None
CDSCO (India) None 2
US FDA None 1

Questions about Meghmani

Does Meghmani hold a US DMF or a CEP?
Meghmani holds 3 active US drug master files and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Meghmani FDA-registered?
2 sites operated by Meghmani carry an FDA establishment identifier (FEI), which means they are registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Meghmani's last inspection go?
The most recent inspection on record closed on 3 February 2026 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 1 inspection is on file.
Where does Meghmani manufacture?
5 registered sites are on record, in India (Ahmedabad, Dahej and Bharuch among others). Every site is listed on this page with the register it came from.
What does Meghmani make?
1 molecule is on record against Meghmani, including Acetaminophen. Each links through to that molecule's full manufacturer list.
Which regulators recognise Meghmani's GMP?
Current GMP certificates are on record from CDSCO (India) and US FDA. GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Meghmani comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 3 February 2026.

Comparable suppliers

Apitoria Pharma shares 2 molecules Granules India shares 2 molecules Specgx shares 2 molecules IOL Chemicals and Pharmaceuticals shares 2 molecules Anqiu Lu'an Pharmaceutical shares 2 molecules

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates